The results of an analysis published by Cancer Research UK today estimate that more than 21 million UK adults will be obese by 2040

New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month.

A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine.

Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.

Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.